In conversation with... Michael Heneka
from Listen to The Lancet Hosted by The Lancet
Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of Listen to The Lancet?
This episode is 21 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on January 10, 2025.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.